The characteristics of peripheral blood lymphocyte main subsets in rheumatoid arthritis patients concurrent with hepatitis b virus infection: a retrospective cohort study
- PMID: 40221696
- PMCID: PMC11994019
- DOI: 10.1186/s12879-025-10932-4
The characteristics of peripheral blood lymphocyte main subsets in rheumatoid arthritis patients concurrent with hepatitis b virus infection: a retrospective cohort study
Abstract
Objective: The distribution of peripheral blood lymphocytes may change due to the influence of diseases. This study aims to investigate the impact of Hepatitis B virus (HBV) infection on the distribution of peripheral blood lymphocyte subsets in patients with Rheumatoid Arthritis (RA).
Methods: Two hundred ninety-eight patients were recruited from a retrospective cohort of patients with RA. Patients with RA (n = 43) who had hepatitis B surface antigen (HBsAg) positivity in the serum were categorized into the HBV group (HBV-RA group), while 255 RA patients without HBsAg positivity were assigned to the control group. The patients in the HBV-RA group were further divided into two subgroups based on their levels of HBV DNA: those with levels below the lower limit of quantification (< 20 IU/ml) formed the HBV DNAlow group, while those with levels above or equal to this limit (≥ 20 IU/ml) constituted the HBV DNAhigh group. Demographic, clinical and laboratory data were also collected.
Results: Compared with those of the control group, a higher proportion of CD19+ B cells and CD8+ T cells and a lower CD4+/CD8+ ratio were observed in the HBV-RA group (all P < 0.05). The same trend was observed in the HBV DNAhigh group compared to the HBV DNAlow group (all P < 0.05). Additionally, based on multivariable logistic regression analysis, the male gender, DAS-28 ≥ 2.6, a high proportion of CD19 + B and CD8 + T cells, and the elevated levels of rheumatoid factor (RF) were found to be significantly associated with RA concurrent with HBV infection (all P < 0.05). In the HBV-RA group, a correlation analysis was conducted revealing a positive association between CD19 + B cells and DAS-28 score, as well as CD8 + T cells and DAS-28 score. There was no statistically significant difference in CD4/CD8 ratio between different DAS-28 groups, however the study revealed a significant negative association between the ratio of CD4 +/CD8 + and the DAS-28 score.
Conclusion: The high proportion of CD19 + B and CD8 + T cells were closely associated with RA concurrent with HBV infection.
Keywords: Hepatitis B virus; Infection; Peripheral blood lymphocytes; Rheumatoid arthritis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The studies involving human participants were reviewed and approved by Ethics Committee of Affiliated Jinhua Hospital, Zhejiang University School of Medicine [Ethical number 2023(99)] and was conducted in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures

Similar articles
-
Potential role of Vitamin D in immune response in patients with viral hepatitis.Nutrition. 2024 Aug;124:112447. doi: 10.1016/j.nut.2024.112447. Epub 2024 Mar 30. Nutrition. 2024. PMID: 38669827
-
Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.Yonsei Med J. 2018 May;59(3):452-456. doi: 10.3349/ymj.2018.59.3.452. Yonsei Med J. 2018. PMID: 29611409 Free PMC article.
-
Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.Int J Rheum Dis. 2016 May;19(5):470-5. doi: 10.1111/1756-185X.12359. Epub 2014 Apr 4. Int J Rheum Dis. 2016. PMID: 24698305
-
The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis.Clin Rheumatol. 2013 Jun;32(6):787-95. doi: 10.1007/s10067-013-2170-1. Epub 2013 Jan 23. Clin Rheumatol. 2013. PMID: 23340833
-
Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.Clin Exp Rheumatol. 2013 Jan-Feb;31(1):118-21. Epub 2012 Oct 30. Clin Exp Rheumatol. 2013. PMID: 23111095 Review.
References
-
- D’Orazio A, Cirillo AL, Greco G, et al. Pathogenesis of rheumatoid arthritis: one year in review 2024. Clin Exp Rheumatol. 2024;42(9):1707–13. 10.55563/clinexprheumatol/0307ed. - PubMed
-
- Parkin J, Cohen B. An overview of the immune system. Lancet. 2001;357(9270):1777–89. 10.1016/S0140-6736(00)04904-7. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials